相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT4-associated natural killer cell tolerance following liver transplantation
K. M. Jamil et al.
GUT (2017)
CIS is a potent checkpoint in NK cell-mediated tumor immunity
Rebecca B. Delconte et al.
NATURE IMMUNOLOGY (2016)
Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
Alessia Bottos et al.
NATURE COMMUNICATIONS (2016)
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
Dagmar Gotthardt et al.
CANCER DISCOVERY (2016)
Regulation of Natural Killer Cell Function by STAT3
Nicholas A. Cacalano
FRONTIERS IN IMMUNOLOGY (2016)
Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity
Eva Maria Putz et al.
ONCOIMMUNOLOGY (2016)
JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
Kathrin Schoenberg et al.
CANCER RESEARCH (2015)
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
Lorraine Springuel et al.
HAEMATOLOGICA (2015)
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
Maryam Hejazi et al.
HAEMATOLOGICA (2015)
Long-Term Follow-up of STAT5B Deficiency in Three Argentinian Patients: Clinical and Immunological Features
Liliana Bezrodnik et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Alexandra Y. Kreins et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Characterization of tumor infiltrating Natural Killer cell subset
Inbar Levi et al.
ONCOTARGET (2015)
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
Lorraine Springuel et al.
HAEMATOLOGICA (2015)
Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes
Maryam Hejazi et al.
HAEMATOLOGICA (2015)
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
Michaela Prchal-Murphy et al.
ONCOIMMUNOLOGY (2015)
IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness
Andrea Ziblat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
Angelika Berger et al.
Oncotarget (2015)
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Kodappully Sivaraman Siveen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation
Shiguo Zhu et al.
BLOOD (2014)
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
Dagmar Gotthardt et al.
BLOOD (2014)
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal et al.
CANCER RESEARCH (2014)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Inborn errors of the development of human natural killer cells
Emmanuelle Jouanguy et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
T cell regulation of natural killer cells
Yann Kerdiles et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
Cinzia Fionda et al.
JOURNAL OF IMMUNOLOGY (2013)
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Eva Maria Putz et al.
CELL REPORTS (2013)
Epigenetic regulation of NK cell differentiation and effector functions
Frank Cichocki et al.
FRONTIERS IN IMMUNOLOGY (2013)
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Antonino Bruno et al.
NEOPLASIA (2013)
Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes
Stephanie Boisson-Dupuis et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Proinflammatory cytokine signaling required for the generation of natural killer cell memory
Joseph C. Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
Rupsha Fraser et al.
JOURNAL OF PATHOLOGY (2012)
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
Tatsuaki Mizutani et al.
ONCOIMMUNOLOGY (2012)
Natural killer cells: role in local tumor growth and metastasis
Inge Langers et al.
BIOLOGICS-TARGETS & THERAPY (2012)
A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
Eva Eckelhart et al.
BLOOD (2011)
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation
Donatella Vairo et al.
BLOOD (2011)
Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
Romain Bedel et al.
CANCER RESEARCH (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets
Alice Laroni et al.
PLOS ONE (2011)
Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions
Damayanti Chakraborty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Natural Killer Cell Education and Tolerance
Mark T. Orr et al.
CELL (2010)
IL-7 Enhances Survival of Human CD56bright NK Cells
Annie Michaud et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Tumor-associated macrophages: Effectors of angiogenesis and tumor progression
Seth B. Coffelt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Masahiro Matsui et al.
CANCER RESEARCH (2009)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Janus kinases in immune cell signaling
Kamran Ghoreschi et al.
IMMUNOLOGICAL REVIEWS (2009)
IL-21 Enhances NK Cell Activation and Cytolytic Activity and Induces Th17 Cell Differentiation in Inflammatory Bowel Disease
Zhanju Liu et al.
INFLAMMATORY BOWEL DISEASES (2009)
A partial form of recessive STAT1 deficiency in humans
Ariane Chapgier et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
A Programmed Switch from IL-15-to IL-2-Dependent Activation in Human NK Cells
Anne-Helene Pillet et al.
JOURNAL OF IMMUNOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
Role of Stat3 in suppressing anti-tumor immunity
Marcin Kortylewski et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells
L. R. Grant et al.
GENES AND IMMUNITY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Canonical and non-canonical JAK-STAT signaling
Willis X. Li
TRENDS IN CELL BIOLOGY (2008)
Interleukin-21 differentially affects human natural killer cell subsets
Katy Wendt et al.
IMMUNOLOGY (2007)
High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells
Takuya Miyagi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
Control of NK cell functions by CD4(+) CD25(+) regulatory T cells
Natacha Ralainirina et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Activation, coactivation, and costimulation of resting human natural killer cells
Yenan T. Bryceson et al.
IMMUNOLOGICAL REVIEWS (2006)
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Jacob Hanna et al.
NATURE MEDICINE (2006)
Self-tolerance of natural killer cells
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2006)
How do natural killer cells find self to achieve tolerance?
WM Yokoyama et al.
IMMUNITY (2006)
IL-21 down-regulates NKG2D/DAP10 express on human NK and CD8+ T cells
SJ Burgess et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
IL-21 enhances tumor rejection through a NKG2D-dependent mechanism
R Takaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation
SH Robbins et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo
CAJ Vosshenrich et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation of NK cell cytotoxicity
MJ Smyth et al.
MOLECULAR IMMUNOLOGY (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation
JL Roberts et al.
BLOOD (2004)
IL-21 induces the functional maturation of murine NK cells
J Brady et al.
JOURNAL OF IMMUNOLOGY (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Control of Leishmania major in the absence of Tyk2 kinase
U Schleicher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
IL-10 stimulatory effects on human NK cells explored by gene profile analysis
S Mocellin et al.
GENES AND IMMUNITY (2004)
STAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cells
T Katsumoto et al.
JOURNAL OF IMMUNOLOGY (2004)
IFNα regulates NK cell cytotoxicity through STAT1 pathway
SJ Liang et al.
CYTOKINE (2003)
IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells
JH Bream et al.
BLOOD (2003)
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
S Dupuis et al.
NATURE GENETICS (2003)
The human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells
K Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice
K Shimoda et al.
BLOOD (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus
S Mahalingam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The Jak-STAT pathway
K Imada et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
